Agile Therapeutics, Inc. Profile Avatar - Palmy Investing

Agile Therapeutics, Inc.

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combinatio…

Drug Manufacturers - Specialty & Generic
US, Princeton [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Agile Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Agile Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Agile Therapeutics, Inc..

End of AGRX's Analysis
CIK: 1261249 CUSIP: 00847L100 ISIN: US00847L3087 LEI: - UEI: -
Secondary Listings
AGRX has no secondary listings inside our databases.